
Threshold serum concentrations of tumour necrosis factor alpha (TNFα) as a potential marker of the presence of microangiopathy in children and adolescents with type 1 diabetes mellitus (T1DM)
Keywords: AGEs, advanced glycation end products; sRAGE, receptor for the advanced glycation end products; TNFα, tumour necrosis factor alpha; VEG165, vascular endothelial growth factor165; IL-12, interleukin-12; ABPM, ambulatory 24 h blood pressure monitoring; ROC,